Q2 2024 Holdings
Filed 2024-08-14 | 130 holdings | $574.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY)Put | COM | 02043Q107 | $36.5M | 1,500 | 6.3% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $36.5M | 1,500 | 6.3% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $34.0M | 5,070 | 5.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $32.2M | 203,612 | 5.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $26.4M | 588,818 | 4.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $21.8M | 800,277 | 3.8% |
| Amgen Inc(AMGN)Call | COM | 031162100 | $18.7M | 600 | 3.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $18.2M | 445,451 | 3.2% |
| Praxis Precision Medicines I(PRAX)Put | COM NEW | 74006W207 | $17.5M | 4,225 | 3.0% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $15.8M | 1,000 | 2.8% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $15.2M | 6,000 | 2.6% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $14.0M | 309,540 | 2.4% |
| Neurocrine Biosciences Inc(NBIX)Call | COM | 64125C109 | $13.8M | 1,000 | 2.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $13.7M | 586,552 | 2.4% |
| Praxis Precision Medicines I(PRAX)Call | COM NEW | 74006W207 | $12.4M | 3,000 | 2.2% |
| Amgen Inc(AMGN) | COM | 031162100 | $12.0M | 38,300 | 2.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $11.5M | 151,601 | 2.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $9.2M | 170,147 | 1.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.2M | 440,500 | 1.6% |
| Alexandria Real Estate EQ in(ARE)Put | COM | 015271109 | $8.6M | 733 | 1.5% |
| Astrazeneca PLC(AZN)Call | SPONSORED ADR | 046353108 | $8.5M | 1,092 | 1.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $8.4M | 332,013 | 1.5% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $8.0M | 518,386 | 1.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $7.3M | 138,262 | 1.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $7.3M | 276,925 | 1.3% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $6.5M | 242,370 | 1.1% |
| Acelyrin Inc | COM | 00445A100 | $6.5M | 1,475,074 | 1.1% |
| Corcept Therapeutics Inc(CORT)Call | COM | 218352102 | $6.0M | 1,860 | 1.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.5M | 40,000 | 1.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $5.5M | 1,662,408 | 1.0% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $4.8M | 709 | 0.8% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $4.6M | 489,642 | 0.8% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $4.2M | 197,096 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.2M | 107,187 | 0.7% |
| Cervomed Inc(CRVO) | COM | 15713L109 | $4.1M | 237,345 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.9M | 903,744 | 0.7% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $3.8M | 13,953,488 | 0.7% |
| Viridian Therapeutics Inc(VRDN)Put | COM | 92790C104 | $3.6M | 2,789 | 0.6% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $3.5M | 204,513 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $3.3M | 506,665 | 0.6% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $3.3M | 230,000 | 0.6% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $3.3M | 768,593 | 0.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.2M | 47,835 | 0.6% |
| Annovis BIO Inc(ANVS)Put | COM | 03615A108 | $3.2M | 5,517 | 0.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $3.1M | 458,497 | 0.5% |
| G1 Therapeutics Inc(GTHXEUR)Put | COM | 3621LQ109 | $2.9M | 12,864 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $2.9M | 201,116 | 0.5% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $2.9M | 575,088 | 0.5% |
| G1 Therapeutics Inc(GTHXEUR)Call | COM | 3621LQ109 | $2.8M | 12,248 | 0.5% |
| Immunovant Inc(IMVT)Call | COM | 45258J102 | $2.6M | 1,000 | 0.5% |